Claims for Patent: 4,816,470
✉ Email this page to a colleague
Summary for Patent: 4,816,470
| Title: | Heterocyclic compounds |
| Abstract: | Indole derivatives of the general formula (I) are disclosed: ##STR1## where R.sub.1 is H or an alkyl or alkenyl group, R.sub.2 is H, or an alkyl, alkenyl, aryl, aralkyl or cycloalkyl group; R.sub.3 is H or an alkyl group; R.sub.4 and R.sub.5 are independently H or an alkyl or propenyl group or together form an aralkylidene group; and Alk is an optionally substituted alkylene chain; and their physiologically acceptable salts and solutes. These compounds are potentially useful for the treatment of migraine and may be formulated as pharmaceutical compositions in conventional manner. Various methods for the production of the compounds are disclosed including a Fischer-indole cyclization process. |
| Inventor(s): | Dowle; Michael D. (Hertford, GB2), Coates; Ian H. (Hertford, GB2) |
| Assignee: | Glaxo Group Limited ( |
| Application Number: | 06/789,831 |
| Patent Claims: |
1. A compound of formula (I): ##STR7## wherein R.sub.1 represents a hydrogen atom or a C.sub.1-6 alkyl or C.sub.3-6 alkenyl group;
R.sub.2 represents a hydrogen atom or a C.sub.1-3 alkyl, C.sub.3-6 alkenyl, phenyl, phen(C.sub.1-4) alkyl or C.sub.5-7 cycloalkyl group; R.sub.3 represents a hydrogen atom or a C.sub.1-3 alkyl group; R.sub.4 and R.sub.5, which are the same or different, each represents a hydrogen atom or a C.sub.1-3 alkyl or propenyl group or R.sub.4 and R.sub.5 together form a benzylidene group; and Alk represents an alkylene chain containing two or three carbon atoms which is unsubstituted or substituted by not more than two C.sub.1-3 alkyl groups, and physiologically acceptable salts and solvates thereof. 2. A compound according to claim 1, wherein, in the formula (I), R.sub.1 represents a hydrogen atom or a C.sub.1-6 alkyl group and R.sub.2 represents a hydrogen atom or a C.sub.1-3 alkyl, C.sub.3-6 alkenyl or phen(C.sub.1-4) alkyl group. 3. A compound according to claim 1, wherein in the formula (I), R.sub.3 represents a hydrogen atom. 4. A compound according to claim 1, wherein in the formula (I), R.sub.4 and R.sub.5, which are the same or different, each represents a hydrogen atom or a C.sub.1-3 alkyl group. 5. A compound of the formula (I) ##STR8## wherein R.sub.1 represents a hydrogen atom or a C.sub.1-3 alkyl group; R.sub.2 represents a hydrogen atom or a C.sub.1-3 alkyl group, a C.sub.3-4 alkenyl group or a phen(C.sub.1-2)alkyl group; R.sub.3 represents a hydrogen atom; R.sub.4 and R.sub.5, which are the same or different, each represents a hydrogen atom or a C.sub.1-3 alkyl group; and Alk represents an alkylene chain containing two or three carbon atoms which is unsubstituted or substituted by not more than two C.sub.1-3 alkyl groups, and physiologically acceptable salts and solvates thereof. 6. A compound according to claim 5, wherein in the formula (I): R.sub.1 represents a hydrogen atom or a methyl group; R.sub.2 represents a hydrogen atom or a methyl, ethyl, isopropyl, propenyl or benzyl group; R.sub.3 represents a hydrogen atom; and R.sub.4 and R.sub.5 which may be the same or different, each represents a hydrogen atom or a methyl group. 7. A compound according to claim 6, wherein in the formula (I) Alk represents an unsubstituted alkylene chain containing two or three carbon atoms. 8. A compound according to claim 5, wherein the physiologically acceptable salt is a hydrochloride, hydrobromide, sulphate, fumarate, maleate or succinate. 9. A compound according to claim 8, wherein the physiologically acceptable salt is a succinate. 10. A compound according to claim 5, wherein, in the formula (I), R.sub.1 represents a hydrogen atom or a C.sub.1-3 alkyl group; R.sub.2 represents a C.sub.1-3 alkyl group or a C.sub.3-4 alkenyl group; R.sub.3 and R.sub.4 each represents a hydrogen atom; and R.sub.5 represents a hydrogen atom or a C.sub.1-3 alkyl group. 11. A compound according to claim 1 which is 3-(2-(methylamino)ethyl)-N-methyl-1H-indole-5-methanesulphonamide; 3-(2-aminoethyl)-N,N-dimethyl-1H-indole-5-methanesulphonamide; 3-(2-aminoethyl)-N-(2-propenyl)-1H-indole-5-methanesulphonamide; or a physiologically acceptable salt or solvate thereof. 12. 3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulphonamide or a physiologically acceptable salt or solvate thereof. 13. A compound according to claim 1 wherein the physiologically acceptable salt is a hydrochloride, hydrobromide, sulphate, fumarate, maleate or succinate. 14. 3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulphonamide, hydrochloride; or 3-(2-aminoethyl)-N-methyl-1H-indole-5-methanesulphonamide, succinate. 15. A pharmaceutical composition for use in the treatment of migraine comprising an effective amount of at least one compound of formula (I) as defined in claim 1 or a physiologically acceptable salt or solvate thereof together with one or more physiologically acceptable carriers or excipients. 16. A method of treating a patient suffering from migraine which comprises administering to the patient an effective amount of a compound of formula (I) as defined in claim 1 or a physiologically acceptable salt or solvate thereof. 17. A pharmaceutical composition for use in the treatment of migraine comprising an effective amount of at least one compound of formula (I) as defined in claim 5 or a physiologically acceptable salt or solvate thereof together with one or more physiologically acceptable carriers or excipients. 18. A method of treating a patient suffering from migraine which comprises administering to the patient an effective amount of a compound of formula (I) as defined in claim 5 or a physiologically acceptable salt or solvate thereof. |
